Baycol -

While all statins carry a minor risk of this condition, Baycol’s risk was found to be significantly higher. The danger escalated dramatically when the drug was taken in combination with , another cholesterol medication; in these cases, the risk of muscle destruction was up to 10 times higher than with other statins. The Fall and Recall

By 2001, the evidence became impossible to ignore. Internal documents later suggested that Bayer may have been aware of these risks as early as the drug's US approval in 1997. On , Bayer voluntarily withdrew Baycol from the global market following reports linking it to 31 deaths in the U.S. and dozens more worldwide. Study: Baycol risks greaterthan believed - NBC News baycol

Baycol was fast-acting and highly effective at lower doses than its competitors, quickly becoming Bayer's third best-selling drug. By 2001, it was used by nearly 700,000 people in the United States alone. The Hidden Danger While all statins carry a minor risk of